News
On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...
The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...
Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...
The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...
8h
MedPage Today on MSNFDA Approves New Option for Chronic HivesThe FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...
Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...
As spring transitions into summer in Southern Nevada, bee activity increases significantly, creating both ecological benefits and potential challenges for residents. Understanding how to safely manage ...
Discover the 6 most common causes of mouth rashes in children beyond food allergies, from acidic foods to infections, and ...
Medically reviewed by Corinne Savides Happel, MD A rash around a child's mouth is not usually not due to food allergies. It ...
If a wasp does sting you, Texas Parks and Wildlife suggests the following: Remove the stinger. Washing sting with soap and ...
Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...
The U.S. Food and Drug Administration approved the extended use of Sanofi and Regeneron's blockbuster drug Dupixent for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results